FLINTLOCK Phase 2 clinical trial will evaluate the safety, tolerability, pharmacokinetics, and clinical efficacy of high-dose monoclonal antibody VYD2311 in adults aged 18-65 years with Long COVID or ...
One species is reshaping climate, chemistry, and habitat fast enough to match past planetary die-offs. · 0 sources across the ...